Co-Investing Alongside Private Equity Funds: Opportunities and Risks for HNW Investors

Co-investment — the ability to invest directly in specific portfolio companies alongside a private equity fund manager — has become one of the most sought-after benefits in the alternatives universe. When executed well, it offers the potential for higher net returns than primary fund investing (because fees are lower or absent), faster capital deployment, specific asset selection, and avoidance of the J-curve. When approached carelessly, it can concentrate risk in the GPs' worst deals and expose investors to adverse selection dynamics they may not fully appreciate.

Capital is at risk. Co-investments are illiquid, highly concentrated, and frequently result in partial or total loss. This guide is for information only and does not constitute regulated investment advice. Co-investment opportunities are typically restricted to professional or sophisticated investors.

---

What Is Co-Investment?

When a private equity firm (the GP) acquires a portfolio company, the total transaction size often exceeds what the GP wishes to allocate from its primary fund — whether due to concentration limits, fund size constraints, or regulatory requirements. To complete the deal, the GP may offer co-investment rights to trusted LPs (existing fund investors) or other HNW and institutional co-investors.

The co-investor provides equity capital directly into the deal — typically through a special purpose vehicle (SPV) holding equity in the target company — alongside the PE fund. The co-investor holds the same underlying asset as the fund on substantially the same terms (same entry price, same shareholders' agreement rights for significant co-investors).

---

The Fee Advantage

The most compelling quantitative argument for co-investment is the fee differential:

A primary PE fund typically charges 1.5–2% management fee and a 20% carried interest (performance fee). Over a typical fund life, these fees can absorb 3–5% of invested capital per annum, which is a substantial drag relative to expected gross returns of 20–25%.

Co-investments are frequently offered at zero management fee and zero carried interest — a "0/0" or "no fee, no carry" structure. Some GPs charge a reduced structure such as 0.5% management fee and 10% carry. Even reduced fees represent a significant improvement over primary fund terms.

Over a portfolio of co-investments, this fee saving can add 2–4% per annum to net returns relative to primary fund exposure, assuming equivalent gross returns on the underlying deals.

---

Avoiding the J-Curve

Primary PE funds suffer the J-curve: management fees are charged from day one on committed capital, and it may take two to four years for the fund to deploy most of its capital and begin generating distributions. Early years show negative IRR on a cash-flow basis.

Co-investments deploy capital directly into specific transactions and begin generating returns (or losses) immediately. There is no management fee drag on undeployed capital. This compresses or eliminates the J-curve, which is particularly valuable for investors who want current or near-term portfolio performance rather than accepting years of negative interim returns.

---

Selection Bias and Adverse Selection

The most significant concern in co-investment is adverse selection — the possibility that GPs offer co-investments disproportionately in their weaker deals.

Why might this happen?

• Oversized deals: GPs offer co-investment in deals that are too large for the fund, which may have been bid up to a higher multiple precisely because of auction competition
• Deals requiring validation: GPs may seek co-investors as a signal of external endorsement on deals they themselves have concerns about
• Relationship co-investments: GPs sometimes offer co-investment in troubled situations as a way of managing LP relationships
• Speed constraints: co-investment decisions are required on short timelines (often 1–2 weeks) without the benefit of the GP's full diligence. The investor who cannot complete diligence quickly either passes on everything or accepts on thin analysis

Empirical academic research on co-investment performance has produced mixed results. Some studies find co-investments underperform primary fund investing net of fees even with the fee advantage; others find the reverse. The key variable is co-investment selection discipline: investors who accept all offered co-investments perform worse than those who are selective.

The implication is clear: the ability to say no to individual co-investment opportunities — based on rigorous independent analysis — is as important as the ability to access them in the first place.

---

Deal Flow Sources

Existing LP relationships are the most common source of co-investment opportunities. LPs who commit significant capital to a GP's fund (typically $20–50 million or above) typically receive preferential access to co-investments from that manager. This creates a natural barrier: investors with broad and senior LP relationships across many GP relationships will see more and higher-quality co-investment flow.

Co-investment platforms and networks: a growing ecosystem of intermediaries — placement agents, specialist platforms, family office networks — aggregates co-investment opportunities and presents them to investors without direct GP relationships. The quality and independence of diligence on these platforms varies significantly; investors should scrutinise the source and GP relationship carefully.

Club deals: transactions where a small group of investors (two to five) co-invest alongside each other, sometimes without a single controlling PE firm. Club deals allow each investor to influence deal structuring but require all parties to align on terms, governance and exit strategy — a coordination challenge.

---

SPV Structures

Most co-investments are structured through a special purpose vehicle (SPV): a limited liability company or limited partnership created specifically to hold the co-investor's interest in the target company. The SPV is the legal shareholder; the co-investor holds interests in the SPV.

Key structural considerations:

• Voting and governance rights: does the SPV have board representation or observer rights at the portfolio company? What decisions require SPV consent?
• Tag-along and drag-along rights: can the co-investor "tag along" with the GP's exit on the same terms? Can the GP "drag" the co-investor into a sale it has agreed without consent?
• Information rights: what financial reporting does the co-investor receive on the portfolio company?
• Transfer restrictions: co-investment interests are typically illiquid and subject to transfer restrictions; secondary sale may be possible but at a significant discount

Legal review of SPV documentation by qualified counsel familiar with private equity transactions is strongly advisable before committing capital.

---

Typical Minimum Investments

Co-investment minimums vary widely by manager, transaction size and deal type:

• Institutional co-investments alongside large-cap PE managers: typically $5–25 million minimum per transaction
• Mid-market PE co-investments: $1–5 million typical
• Platform and network-accessed co-investments: some platforms aggregate smaller tickets with minimums of £100,000–£500,000, though investors should assess the additional SPV layer and platform fees carefully
• Family office networks: minimums vary but $500,000–$2 million is common

A meaningful co-investment programme should involve diversification across at least 10–15 transactions to mitigate the binary outcomes from individual deals. At $1 million per investment, this implies a minimum programme size of £10–15 million to be well diversified.

---

Time Pressure and Diligence Constraints

Co-investment offers frequently come with 1–2 week decision deadlines. The GP has completed its own diligence (often over several months) but shares only a summary with co-investors. The co-investor must:

1. Understand the investment thesis and business
2. Verify valuation assumptions
3. Assess management quality and competitive position
4. Review legal documents

All under time pressure and with incomplete information. This is difficult for individual investors without dedicated private equity expertise. Working with an advisory firm that can accelerate and structure the diligence process is significantly advantageous.

---

Risks

Concentration: a co-investment is 100% in a single company. If that company fails, the capital is lost.

Illiquidity: no exit until the GP's chosen exit — typically a trade sale or IPO — which may be 3–7 years or longer.

Information asymmetry: the GP knows more about the business than the co-investor.

GP alignment: the GP's interests and co-investor interests may diverge, particularly if the portfolio company requires additional capital ("pay-to-play" provisions) or if the exit timeline is influenced by the fund's own lifecycle.

---

How Global Investments Can Help

We maintain relationships with private equity managers across buyout, growth, venture and real assets, and can provide access to co-investment opportunities appropriate for sophisticated investors. Our team conducts independent diligence on co-investment opportunities, advises on SPV terms and governance rights, and helps construct a co-investment programme with appropriate diversification across manager, sector and geography. We can also assist with portfolio monitoring and exit planning for existing co-investment positions.

Contact us to discuss co-investment access and private equity deal flow.